alexa Vitamin k Antagosnist Oral Anticoagulants

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Vitamin k Antagosnist Oral Anticoagulants

Vitamin k Antagosnist Oral Anticoagulants (VKA) is effective in the primary and secondary prevention of venous thromboembolism, in the prevention of systemic embolism and stroke in patients with prosthetic heart valves or atrial fibrillation. In patients with thromboembolic disease Low Molecular Weight Heparin (LMWH) and oral VKA are started at diagnosis. LMWH is than stopped once the International Normalised Ratio (INR) values are in the therapeutic range.

 

Citation: https://www.omicsonline.org/open-access/paradoxical-increased-risk-of-thrombosis-after-initiation-of-vitamin-k-antagonists-in-thromboembolic-disease-2165-7920.1000e121.php?aid=22348

 

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger